(NEWSER) - A group of breast cancer and ovarian cancer patients has filed suit against the Patent Office for allowing a company to patent two human genes, the Courthouse News Service reports. The plaintiffs, who also include medical organizations and the ACLU, allege that Myriad Genetics' patents on the BRCA1 and BRCA2 genes mean women are unlawfully "prevented from obtaining information about their health risks from anyone other than the patent holder." More»
